NO880141L - Forbedret fibrinolytisk blanding. - Google Patents
Forbedret fibrinolytisk blanding.Info
- Publication number
- NO880141L NO880141L NO880141A NO880141A NO880141L NO 880141 L NO880141 L NO 880141L NO 880141 A NO880141 A NO 880141A NO 880141 A NO880141 A NO 880141A NO 880141 L NO880141 L NO 880141L
- Authority
- NO
- Norway
- Prior art keywords
- fibrinolytic
- cho
- composition
- enzyme
- mixing
- Prior art date
Links
- 239000003527 fibrinolytic agent Substances 0.000 title abstract 2
- 230000003480 fibrinolytic effect Effects 0.000 title abstract 2
- 208000007536 Thrombosis Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 101710196208 Fibrinolytic enzyme Proteins 0.000 abstract 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 abstract 1
- 108010023197 Streptokinase Proteins 0.000 abstract 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 abstract 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 abstract 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 abstract 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000007859 condensation product Substances 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 210000004351 coronary vessel Anatomy 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 229960005202 streptokinase Drugs 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 229960000187 tissue plasminogen activator Drugs 0.000 abstract 1
- 229960005356 urokinase Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
En blanding son effektivt oppleser blodklumper og reetable-. rer og oppretter blodstrømmen gjennom kransarterier eller andre blodkar hvor det har vært en trombose. Den fibrinolytiske blandingen ifølge foreliggende oppfinnelse består av et enzym, f.eks. streptokinase, urokinase, vevsplasminogenaktivator eller et annet fibrinolytisk enzym, og en overflateaktiv kopolymer. Sistnevnte kan vsre et etylenoksyd-propylenoksyd-kondensasjons-produkt med følgende generelle formel:. hvor a er et tall, slik at den hydrofobe delen representert ved (CH0), har en molekylvekt fra ca. 950 til 4000, fortrinnsvis fra 175til 4000, og b er et slikt tall at den hydrofile delen representert ved (CH0), utgjør fra ca. 50 til ca. 90 vekt% av forbindelsen.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO922262A NO922262D0 (no) | 1986-05-15 | 1992-06-09 | Forbedret fibrinolytisk blanding |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86358286A | 1986-05-15 | 1986-05-15 | |
| US4388887A | 1987-04-29 | 1987-04-29 | |
| US07/045,459 US4801452A (en) | 1986-05-15 | 1987-05-07 | Fibrinolytic composition |
| PCT/US1987/001067 WO1987006836A1 (en) | 1986-05-15 | 1987-05-08 | Fibrinolytic composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO880141D0 NO880141D0 (no) | 1988-01-14 |
| NO880141L true NO880141L (no) | 1988-03-14 |
Family
ID=27488885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO880141A NO880141L (no) | 1986-05-15 | 1988-01-14 | Forbedret fibrinolytisk blanding. |
Country Status (2)
| Country | Link |
|---|---|
| MC (1) | MC1856A1 (no) |
| NO (1) | NO880141L (no) |
-
1987
- 1987-05-08 MC MC87US8701067D patent/MC1856A1/xx unknown
-
1988
- 1988-01-14 NO NO880141A patent/NO880141L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO880141D0 (no) | 1988-01-14 |
| MC1856A1 (fr) | 1988-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3855096T2 (de) | Hemmung von arteriellem thrombotischen Verschluss oder von Thrombo-Embolismus | |
| ES2009264A6 (es) | Procedimiento de obtencion de una composicion fibrinolitica mejorada. | |
| Tamao et al. | Effect of a selective thrombin inhibitor MCI-9038 on fibrinolysis in vitro and in vivo | |
| IE48478B1 (en) | Enzyme derivatives for use in the treatment of venous thrombosis,compositions containing them and their preparation | |
| ATE108206T1 (de) | Gewebe-plasminogenaktivator. | |
| JPS6236502B2 (no) | ||
| Dosekun et al. | Ancrod in systemic lupus erythematosus with thrombosis: clinical and fibrinolysis effects | |
| CA2194692A1 (en) | Fibrin(ogen) degradation and clot lysis by fibrinolytic matrix metalloproteinase | |
| SE8301795L (sv) | Plasminogenaktivatorkomplex | |
| ES2085326T3 (es) | Activador de plasminogeno salivar del murcielago vampiro vpa-alfa1. | |
| EP0624642B1 (en) | Novel thrombolytic agent, process for preparing same and its use for the preparation of a thrombi dissolving medicament | |
| NO880141L (no) | Forbedret fibrinolytisk blanding. | |
| US4349630A (en) | Heat-resistant water soluble urokinase derivative | |
| KR960006920A (ko) | 혈액 항응고제에 대한 해독제로서 사용하기에 적합한 약제 및 이의 용도 | |
| KR0127776B1 (ko) | 신규한 단백질 분해효소의 cDNA 서열 및 그로 부터 유래된 단백질 | |
| Miller et al. | Degradation of Fibrinogen by Proteolytic Enzymes | |
| HUT59610A (en) | Process for producing pharmaceutical compositions for solving blood clot containing t-pa without glycosilyzing | |
| ES2022934B3 (es) | Enzimas modificadas con poliuretano. | |
| DE68912383T2 (de) | Plasminogenaktivator und thrombolytischer Wirkstoff. | |
| IE922400L (en) | Composition comprising an oxygen radical scavenger and a¹surface-active copolymer | |
| Konttinen | The effect of heparin on the fibrinolytic activity of streptokinase-activated human plasma | |
| Nguyen et al. | A thromboresistant surface by enzyme immobilization | |
| RU1838311C (ru) | Способ получени 2-(3-пиридил)тетрагидротиапиранкарботиоамид-2-оксида-1(1R, 2R) | |
| KR100326941B1 (ko) | 갯지렁이로부터 분리한 신규한 프로테아제 | |
| Forbes et al. | Thrombolytic Therapy—Indications, Advantages and Disadvantages |